On Thursday, the Food and Drug Administration's committee on compounded drugs voted to add peptides to the permitted compounding list. The decision was made despite opposition from agency scientists, who raised concerns regarding a lack of demonstrated benefits for the substances.
The vote allows compounding pharmacies to continue making products containing peptides. However, the move represents a direct break with the technical staff and scientific experts within the regulatory agency who had advised against the inclusion.
In-depth summary · AI, neutral